CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Taperloc Complete Microplasty stem +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03409666
NCT03409666N/ACompleted
CompareCT.gov

Randomized Controlled Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty.

Zimmer Biomet·interventional·Posted Jan 24, 2018·Updated Jul 14, 2022

In Brief

A clinical study evaluating Taperloc Complete Microplasty stem and Taperloc Complete Reduced Distal stem for Hip Osteoarthritis and 4 related conditions. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This is a single center, prospective, randomized controlled study. The primary objective of this study is to measure migration over two years with RSA. Patients will be randomized in two arms, receiving a Taperloc Complete Reduced Distal or a Taperloc Complete Microplasty hip stem.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHip Osteoarthritis, Noninflammatory Degenerative Joint Disease, Avascular Necrosis, Correction of Functional Deformity, Rheumatoid Arthritis
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 24, 2018
Enrollment StartMay 12, 2017
Primary CompletionNov 6, 2020
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 8.4 years ago

Interventions

Taperloc Complete Microplasty stemdevice

Total hip replacement with Taperloc Complete Microplasty stem and G7 acetabular shell with E1 liner

Taperloc Complete Reduced Distal stemdevice

Total hip replacement with Taperloc Complete Reduced Distal stem and G7 acetabular shell with E1 liner